Accessibility Menu
 
Rafarma Pharmaceuticals logo

Rafarma Pharmaceuticals

(OTC) RAFA

Current Price$0.07
Market Cap$6.42M
Since IPO (2012)-97%
5 Year-97%
1 Year-51%
1 Month-14%

Rafarma Pharmaceuticals Financials at a Glance

Market Cap

$6.42M

Revenue (TTM)

$9.14M

Net Income (TTM)

$306.00K

EPS (TTM)

$0.00

P/E Ratio

19.68

Dividend

$0.00

Beta (Volatility)

0.35 (Low)

Price

$0.07

Volume

553

Open

$0.07

Previous Close

$0.07

Daily Range

$0.07 - $0.07

52-Week Range

$0.00 - $0.15

RAFA News

No articles available.

RAFA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Rafarma Pharmaceuticals

Industry

Pharmaceuticals

CEO

Raivo Unt

Headquarters

Sandy, UT 84070, US

RAFA Financials

Key Financial Metrics (TTM)

Gross Margin

7%

Operating Margin

5%

Net Income Margin

3%

Return on Equity

3%

Return on Capital

4%

Return on Assets

2%

Earnings Yield

5.08%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.42M

Shares Outstanding

93.17M

Volume

553

Short Interest

0.00%

Avg. Volume

27.36K

Financials (TTM)

Gross Profit

$674.00K

Operating Income

$405.00K

EBITDA

$342.00K

Operating Cash Flow

$44.00K

Capital Expenditure

$44.00K

Free Cash Flow

$0.00

Cash & ST Invst.

$77.00K

Total Debt

$0.00

Rafarma Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2024YOY CHG

Revenue

$278.00K

+26.4%

Gross Profit

$119.00K

+63.0%

Gross Margin

42.81%

N/A

Market Cap

$6.42M

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$74.00K

+117.6%

EBITDA

$92.00K

+19.8%

Quarterly Fundamentals

Name
Q4 2024YOY CHG

Net Cash

$77.00K

+16.7%

Accounts Receivable

$1.62M

-13.8%

Inventory

$156.00K

+67.7%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

2.40%

N/A

Return on Invested Capital

4.13%

N/A

Free Cash Flow

$1.00K

-100.6%

Operating Cash Flow

$1.00K

-100.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BIOEBio Essence Corporation
$0.17+13.01%
UBQUUbiquitech Software Corp.
$0.00+0.00%
NRPRResilient Healthcare Corp
$0.02+0.00%
RVVTFRevive Therapeutics Ltd.
$0.03-28.57%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.62-0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.61+0.00%
IBRXImmunityBio
$7.42-0.21%
SMCISuper Micro Computer
$22.23+0.03%

Questions About RAFA

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.